Travoprost
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | generic | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Travoprost Ophthalmic Solution — reported in shortage by Mylan Pharmaceuticals Inc., a Viatris Company. Therapeutic category: Ophthalmology.
Travoprost Ophthalmic Solution — reported in shortage by Mylan Pharmaceuticals Inc., a Viatris Company. Therapeutic category: Ophthalmology.
Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing. — Recalling firm: Mylan Pharmaceuticals Inc — Nationwide in the USA and Puerto Rico
